Vanderbilt University Medical Center and Parse Biosciences, an innovator in single-cell sequencing, are collaborating on a new treatment to help unvaccinated measles victims, as the U.S. measles outbreak has now reached its…
Vanderbilt and Parse Biosciences team up to develop antibody treatments for measles
